Det er derfor vigtigt, at patienten undersøges jævnligt, og at der reduceres til den laveste dosis inhalationssteroid, der giver astmakontrol.
There is also an increased risk of systemic side effects when combining fluticasone propionate with other potent CYP3A inhibitors (see 4.5 Interaction with Other Medicinal Products and Other Forms of Interaction).